Connection

SAMEER JHAVAR to Male

This is a "connection" page, showing publications SAMEER JHAVAR has written about Male.
Connection Strength

0.219
  1. Risk factors for locoregional relapse after radical nephrectomy. Asia Pac J Clin Oncol. 2018 Jun; 14(3):192-197.
    View in: PubMed
    Score: 0.022
  2. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival. Asia Pac J Clin Oncol. 2018 Apr; 14(2):e88-e94.
    View in: PubMed
    Score: 0.022
  3. Durability of Artificial Urinary Sphincter With Prior Radiation Therapy. Clin Genitourin Cancer. 2017 04; 15(2):e175-e180.
    View in: PubMed
    Score: 0.021
  4. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int. 2009 May; 103(9):1256-69.
    View in: PubMed
    Score: 0.012
  5. Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer Prostatic Dis. 2009; 12(2):143-7.
    View in: PubMed
    Score: 0.012
  6. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn. 2008 Jan; 10(1):50-7.
    View in: PubMed
    Score: 0.011
  7. Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nat Clin Pract Urol. 2007 Dec; 4(12):677-87.
    View in: PubMed
    Score: 0.011
  8. Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer. 2005 Aug 22; 93(4):478-82.
    View in: PubMed
    Score: 0.010
  9. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol. 2005 May; 58(5):504-8.
    View in: PubMed
    Score: 0.010
  10. Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol. 2004 Jan; 40(1):84-91.
    View in: PubMed
    Score: 0.009
  11. Holmium Laser Enucleation of Prostate in Patients with Pre-Existing Localized Prostate Cancer, Dual Center Study. J Endourol. 2023 03; 37(3):330-334.
    View in: PubMed
    Score: 0.008
  12. Ad Astra - telomeres in space! Int J Radiat Biol. 2022; 98(3):395-403.
    View in: PubMed
    Score: 0.007
  13. Primary extranodal mucosa associated lymphoid tissue (MALT) lymphoma of the prostate. Leuk Lymphoma. 2001 Apr; 41(3-4):445-9.
    View in: PubMed
    Score: 0.007
  14. To B(iopsy) or not to B(iopsy). J Cancer Res Ther. 2017 Oct-Dec; 13(6):1065-1067.
    View in: PubMed
    Score: 0.006
  15. High-density tissue microarrays from prostate needle biopsies. J Clin Pathol. 2011 Jan; 64(1):88-90.
    View in: PubMed
    Score: 0.004
  16. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One. 2010 Oct 13; 5(10):e13363.
    View in: PubMed
    Score: 0.003
  17. Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer. 2010 Sep 07; 103(6):918-24.
    View in: PubMed
    Score: 0.003
  18. The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practice. J Med Genet. 2010 Jul; 47(7):486-91.
    View in: PubMed
    Score: 0.003
  19. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009 Oct; 41(10):1058-60.
    View in: PubMed
    Score: 0.003
  20. An improved method for constructing tissue microarrays from prostate needle biopsy specimens. J Clin Pathol. 2009 Aug; 62(8):694-8.
    View in: PubMed
    Score: 0.003
  21. Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol. 2009 Feb; 82(974):148-56.
    View in: PubMed
    Score: 0.003
  22. Identification of new genetic risk factors for prostate cancer. Asian J Androl. 2009 Jan; 11(1):49-55.
    View in: PubMed
    Score: 0.003
  23. TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer. 2008 Dec 02; 99(11):1849-58.
    View in: PubMed
    Score: 0.003
  24. Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol. 2008 Jun; 81(966):456-62.
    View in: PubMed
    Score: 0.003
  25. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol. 2008 Apr; 9(4):342-51.
    View in: PubMed
    Score: 0.003
  26. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008 Mar; 40(3):316-21.
    View in: PubMed
    Score: 0.003
  27. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene. 2008 Mar 27; 27(14):1993-2003.
    View in: PubMed
    Score: 0.003
  28. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene. 2007 Apr 19; 26(18):2667-73.
    View in: PubMed
    Score: 0.003
  29. Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Feb; 14(2):397-402.
    View in: PubMed
    Score: 0.002
  30. Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer. 2005 Jan 31; 92(2):376-81.
    View in: PubMed
    Score: 0.002
  31. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene. 2004 Aug 05; 23(35):5871-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.